Periodicidad semestral: flujo continuo.
ISSN - Electrónico: 2661-6947 / DOI: 10.36015 • LILACS BIREME (19784); LATINDEX (20666)
Introducción: Cardiovascular complications are among the leading causes of mortality in chronic renal failure patients. Detecting heart failure in early stages of asymptomatic patients has become a challenge and new strategies are needed to prevent and provide these patients with proper management. Since early recognition is crucial, echocardiography has become the cornerstone when used in chronic renal failure patients undergoing dialysis. The standard of care recommends early assessment in the first three months after dialysis started. Methods: A cross-sectional study was conducted at Carlos Andrade Marín Hospital with 61 patients having Renal Replacement Therapy. Brain Natriuretic Peptide (BNP) levels were compared to resting echocardiography for early identification of patients at risk of heart failure. Results: A 29% (95% CI: 0.15 to 0.43) prevalence of heart failure was observed in this group of patients. BNP sensitivity was 58% (95% CI: 0.32 to 0.81), specificity 62% (95% CI: 0.44 – 0.77), PPV 39% (95% CI: 0.16 – 0.61) and NPV 78% (95% CI: 0.61 to 0.95) to identify H.F. As much as 93% of our patients had cardiovascular problems identified by echocardiography. The most frequent abnormality was left ventricular diastolic dysfunction in 36% of cases. Discusion: There is a high prevalence of asymptomatic heart failure patients among dialytic users that should be recognized earlier. Regardless of the absolute BNP values, biomarkers are unsuitable to identify heart failure in renal patients. Echocardiography remains as a useful tool to assess here at function in renal patients.
De la Serna Fernando PHD. Epidemiología de la insuficiencia cardiaca. Revista Española Cardiología 2000.
Ruiz Ortega Raúl Antonio Md, Manzano Luis Md. Diagnóstico de la insuficiencia cardiaca aguda y relevancia de los biomarcadores En pacientes de edad avanzada, Med Clin (Barc). 2014;142(Supl 1):20-25.
Orozco Rodrigo Md. The cardiovascular disease in chronic kidney disease (ckd), Rev. Med. Clin. Condes - 2015; 26(2) 142-155.
Oms. Datos y Estadísticas Sanitarias Mundiales, 2015.
Qiangjun Cai, Yenkata k. Mukku and Masood ahmad, Coronary artery disease in patients with chronic kidney disease: a clinical update, current cardiology reviews, 2013, 9, 331-339.
Cárdenas Tamara IRM, Sánchez Paúl Md, Manjares Luis Md. Prevalencia Y etiología de enfermedad Renal crónica en el Hospital Carlos Andrade Marín, 2012.
Jose e. Castellanos Heredia, Edelsy Morales Jimenez, Alexis Mayo Salazar, Saili Paez Quevedo. Enfermedad cardiovascular en pacientes con Insuficiencia Renal Crónica Estadios IV Y v, artículo original, insuficiencia cardiaca vol. 9 - nº 3 (2014): 105-111.
Goicochea Marian, Md. Enfermedad cardiovascular en pacientes con estadios 4 y 5 de enfermedad renal crónica. Pacientes en diálisis crónica; nefrología. Volumen 24. Suplemento nº 6 • 2004, 143:160.
Aditi mallick y James l. Januzzi jr.; Mds. Biomarcadores en la insuficiencia cardiaca aguda, rev esp cardiol. 2015;68(6):514–525.
Borja Quiroga, Goicoechea Marian, García Soledad, MDs. Marcadores cardiacos en diferentes grados de enfermedad renal crónica: Influencia de la inflamación y de la afectación cardiaca previa; artículo original, Med. Clin. (Barcelona). 2012;139 (3): 98–102.
Borja Quiroga Gili, Md. Valor predictivo de los nuevos biomarcadores cardiacos y de los parámetros ecocardiográficos en hemodiálisis, Universidad Complutense, Madrid 2014.
Almenar Bonet Luis, y Martínez-Dolz Luis, MDs. Péptidos natriuréticos en insuficiencia cardiaca, Revista española cardiología supl. 2006;6:15f-26f
Saldarriaga Giraldo Clara, Jiménez Gómez Carlos, MDs. Brain natriuretic peptide: clinical utility Revista española cardiología supl. 2006;6:15f-26f.
Han-na kim, James l. Januzzi, jr, MDs. Determinación del péptido natriurético en la insuficiencia cardiaca; cardiology division, Massachusetts General Hospital, Boston MA, circulationaha.110.
Andrew Ludman consultant cardiologist, Dworzynski Katharina senior research fellow, Abdallah Al-Mohammad consultant cardiologist. The diagnostic accuracy of the natriuretic peptides in heart failure: Systematic review and diagnostic meta-analysis in the acute care setting; bmj 2015;350
Valdebenito Martín, Paredes Alejandro, Baeza Ricardo, Castro Pablo, Jalil Jorge, MDs. Utilidad diagnóstica del péptido natriurético tipo B en pacientes con insuficiencia cardiaca y enfermedad renal crónica; Rev. Chilena cardiología 2014; 33: 51-57.
Silvio Henrique Barberato e Pecoits- Filho Roberto, MDs. Review article. Echocardiographic alterations in patients with chronic kidney failure undergoing hemodialysis, Pontifícia Universidade Católica do Paraná, Curitiba, Brasil. Octubre 2008.
Pecoits-Filho Roberto, Silvio Henrique Barberato, MDs. Práctica Clínica. Echocardiography In chronic kidney disease: diagnostic And prognostic implications nephron clin pract 2010;114:C242–C247.
Mas-Stachurska Aleksandra, Miro Oscar, Sitges Marta, MDs. Evaluación del dolor torácico agudo mediante ecocardiografía de ejercicio
y tomografía computarizada multidetectores, artículo original, Rev Esp cardiol. 2015;68(1):17–24.
Salim Ahumada, Restrepo Gustavo, MDs. Ecocardiografía en infarto agudo del miocardio, Rev Colomb Cardiol. 2014;21(3):164-173.
Gómez Pulido Fedérico, Gonzales Vargas Manuel Fernando, Junco Domínguez María Victoria; MDs. Hallazgos ecocardiográficos en pacientes con insuficiencia renal crónica terminal en el estudio pretrasplante renal, Rev Esp Cardiol. 2010; 63 supl 3:145.
Jimeno F, Espinoza R, MDs; Diagnóstico y evolución ecocardiográfica en pacientes con insuficiencia renal crónica en hemodiálisis, nefrologia. Vol. XVI. Núm. 3. 1996.
The authors who publish in this journal accept the following conditions:
1. The authors retain the copyright and grant to the CAMbios MEDICAL-SCIENTIFIC JOURNAL HECAM the right of the first publication, with the work registered with the Creative Commons attribution license, which allows third parties to use the published material provided that they mention the authorship of the work and the first publication in this journal.
2. Authors can make other independent and additional contractual agreements for the non-exclusive distribution of the version of the article published in this journal (for example, include it in an institutional repository or publish it in a book) as long as it clearly indicates that the work was published. for the first time in the CAMbios MEDICAL-SCIENTIFIC JOURNAL HECAM.